148 related articles for article (PubMed ID: 17400062)
1. Mechanisms of prolongation of allograft survival by HLA-G/ILT4-modified dendritic cells.
Ristich V; Zhang W; Liang S; Horuzsko A
Hum Immunol; 2007 Apr; 68(4):264-71. PubMed ID: 17400062
[TBL] [Abstract][Full Text] [Related]
2. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway.
Liang S; Ristich V; Arase H; Dausset J; Carosella ED; Horuzsko A
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8357-62. PubMed ID: 18550825
[TBL] [Abstract][Full Text] [Related]
3. Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G.
Liang S; Horuzsko A
Hum Immunol; 2003 Nov; 64(11):1025-32. PubMed ID: 14602231
[TBL] [Abstract][Full Text] [Related]
4. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor.
Liang S; Baibakov B; Horuzsko A
Eur J Immunol; 2002 Sep; 32(9):2418-26. PubMed ID: 12207326
[TBL] [Abstract][Full Text] [Related]
5. Tolerization of dendritic cells by HLA-G.
Ristich V; Liang S; Zhang W; Wu J; Horuzsko A
Eur J Immunol; 2005 Apr; 35(4):1133-42. PubMed ID: 15770701
[TBL] [Abstract][Full Text] [Related]
6. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.
Zhang W; Liang S; Wu J; Horuzsko A
Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.
Gregori S; Tomasoni D; Pacciani V; Scirpoli M; Battaglia M; Magnani CF; Hauben E; Roncarolo MG
Blood; 2010 Aug; 116(6):935-44. PubMed ID: 20448110
[TBL] [Abstract][Full Text] [Related]
8. Isoforms of human leukocyte antigen-G and their inhibitory receptors in human kidney allograft acceptance.
Wu J; Zhang W; Hernandez-Lopez P; Fabelo E; Parikh M; Mulloy LL; Horuzsko A
Hum Immunol; 2009 Dec; 70(12):988-94. PubMed ID: 19664670
[TBL] [Abstract][Full Text] [Related]
9. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice.
Horuzsko A; Lenfant F; Munn DH; Mellor AL
Int Immunol; 2001 Mar; 13(3):385-94. PubMed ID: 11222508
[TBL] [Abstract][Full Text] [Related]
10. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells.
Le Rond S; Azéma C; Krawice-Radanne I; Durrbach A; Guettier C; Carosella ED; Rouas-Freiss N
J Immunol; 2006 Mar; 176(5):3266-76. PubMed ID: 16493088
[TBL] [Abstract][Full Text] [Related]
11. [Induction of tolerogenic dendritic cells by membrane-bound HLA-G in vitro].
Zhou H; Li WM; Zhang M; Liu ZR; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):369-72. PubMed ID: 17493349
[TBL] [Abstract][Full Text] [Related]
12. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.
LeMaoult J; Zafaranloo K; Le Danff C; Carosella ED
FASEB J; 2005 Apr; 19(6):662-4. PubMed ID: 15670976
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells.
Wu J; Horuzsko A
Hum Immunol; 2009 May; 70(5):353-6. PubMed ID: 19405174
[TBL] [Abstract][Full Text] [Related]
14. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2.
Huang J; Burke P; Yang Y; Seiss K; Beamon J; Cung T; Toth I; Pereyra F; Lichterfeld M; Yu XG
J Virol; 2010 Oct; 84(20):10784-91. PubMed ID: 20702625
[TBL] [Abstract][Full Text] [Related]
15. [ILT3+/ILT4+ tolerogenic dendritic cells and their influence on allograft survival].
Arboleda JF; García LF; Alvarez CM
Biomedica; 2011 Jun; 31(2):281-95. PubMed ID: 22159546
[TBL] [Abstract][Full Text] [Related]
16. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
17. Induction of kidney allograft tolerance by soluble CD83 associated with prevalence of tolerogenic dendritic cells and indoleamine 2,3-dioxygenase.
Lan Z; Ge W; Arp J; Jiang J; Liu W; Gordon D; Healey D; DeBenedette M; Nicolette C; Garcia B; Wang H
Transplantation; 2010 Dec; 90(12):1286-93. PubMed ID: 21076370
[TBL] [Abstract][Full Text] [Related]
18. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
[TBL] [Abstract][Full Text] [Related]
19. Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells.
Gregori S; Magnani CF; Roncarolo MG
Hum Immunol; 2009 Dec; 70(12):966-9. PubMed ID: 19664675
[TBL] [Abstract][Full Text] [Related]
20. Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.
Smyth LA; Ratnasothy K; Moreau A; Alcock S; Sagoo P; Meader L; Tanriver Y; Buckland M; Lechler R; Lombardi G
J Immunol; 2013 May; 190(9):4848-60. PubMed ID: 23536635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
